ketoconazole has been researched along with cabergoline in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.35) | 18.2507 |
2000's | 3 (13.04) | 29.6817 |
2010's | 16 (69.57) | 24.3611 |
2020's | 3 (13.04) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Abs, R; Berwaerts, J; Mahler, C; Verhelst, J | 1 |
Cabrera Blatter, MF; Castillo, VA; García, JD; Gómez, NV; Lalia, JC | 1 |
Schteingart, DE | 1 |
Agra, R; Albuquerque, JL; Arahata, CM; Arruda, MJ; Azevedo, MF; Canadas, V; Montenegro, L; Moura E Silva, L; Naves, LA; Pontes, L; Vilar, L | 1 |
de Bruin, C; de Herder, WW; de Jong, FH; Feelders, RA; Hermus, AR; Hofland, LJ; Lamberts, SW; Netea-Maier, RT; Pereira, AM; Romijn, JA; van der Lely, AJ; van Heerebeek, R; Zelissen, PM | 1 |
de Bruin, C; de Herder, WW; de Jong, FH; de Maat, MP; Feelders, RA; Hermus, AR; Hofland, LJ; Lamberts, SW; Leebeek, FW; Netea-Maier, RT; Pereira, AM; Rijken, DC; Romijn, JA; van der Lely, AJ; van der Pas, R; Zelissen, PM | 1 |
Ahmed, A; Furqan, S; Islam, N | 1 |
Barahona Constanzo, MJ; del Pozo Picó, C | 1 |
de Bruin, C; de Herder, WW; de Jong, FH; Feelders, RA; Hermus, AR; Hofland, LJ; Lamberts, SW; Netea-Maier, RT; Pereira, AM; Romijn, JA; van der Lely, AJ; van der Pas, R; Webb, SM; Zelissen, PM | 1 |
Albiger, N; Barbot, M; Ceccato, F; Denaro, L; Frigo, AC; Mantero, F; Scaroni, C; Zilio, M | 1 |
Krysiak, R; Okopien, B | 1 |
Gadelha, MR; Vieira Neto, L | 1 |
Hamrahian, AH; Hoffman, AR; Yuen, KC | 1 |
Ayala, A; Biller, BMK; Bonert, V; Broder, MS; Carmichael, JD; Cherepanov, D; Eagan, M; Geer, EB; Gordon, MB; Hannoush, Z; Katznelson, L; Lalazar, Y; Lee, J; Manuylova, E; Neary, MP; Pulaski-Liebert, KJ; Said, Q; Shafiq, I; Surampudi, V; Swerdloff, RS | 1 |
Seow, CJ; Young, WF | 1 |
Borson-Chazot, F; Ilie, MD; Raverot, G; Raverot, V; Tronc, F; Vasiljevic, A | 1 |
Biller, BMK; Tritos, NA | 1 |
Arvigo, M; Bruzzone, E; Dogan, F; Feelders, RA; Ferone, D; Gatto, F; Hofland, L; Lamberts, S; van der Pas, R; van Koetsveld, P | 1 |
Boguszewski, CL; Marques, JVO | 1 |
Costa, MCB; Czepielewski, MA; de Melo, RB; Mattos, ACV; Rodrigues, TDC; Viecceli, C | 1 |
8 review(s) available for ketoconazole and cabergoline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature.
Topics: Adult; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Ketoconazole; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 1999 |
Drugs in the medical treatment of Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Antiparkinson Agents; Cabergoline; Cushing Syndrome; Ergolines; Human Growth Hormone; Humans; Hydrocortisone; Ketoconazole; Metyrapone; Pituitary Hormones; Pituitary Neoplasms | 2009 |
New prospects for drug treatment in Cushing disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin | 2012 |
Efficacy of medical treatment in Cushing's disease: a systematic review.
Topics: Cabergoline; Ergolines; Female; Humans; Ketoconazole; Male; Metyrapone; Mitotane; Pituitary ACTH Hypersecretion; Somatostatin | 2014 |
AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease.
Topics: Adrenocorticotropic Hormone; Cabergoline; Drug Therapy, Combination; Ergolines; Humans; Ketoconazole; Mifepristone; Pituitary ACTH Hypersecretion; Somatostatin | 2014 |
Medical Management of Cushing Disease.
Topics: Cabergoline; Etomidate; Humans; Ketoconazole; Metyrapone; Mitotane; Pituitary ACTH Hypersecretion; Somatostatin; Temozolomide; Treatment Outcome | 2019 |
Medical therapy in severe hypercortisolism.
Topics: Cabergoline; Cushing Syndrome; Humans; Ketoconazole; Metyrapone; Mitotane | 2021 |
4 trial(s) available for ketoconazole and cabergoline
Article | Year |
---|---|
Cushing's disease in dogs: cabergoline treatment.
Topics: Adrenocorticotropic Hormone; alpha-MSH; Animals; Cabergoline; Dog Diseases; Dogs; Dopamine Agonists; Ergolines; Female; Ketoconazole; Male; Pituitary ACTH Hypersecretion; Time Factors | 2008 |
Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.
Topics: Adult; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Pituitary ACTH Hypersecretion; Prospective Studies; Receptors, Dopamine D2; Receptors, Somatostatin; Somatostatin | 2010 |
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Factors; Cabergoline; Dopamine Agonists; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Ergolines; Fibrinolysis; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Hormones, Anterior; Remission Induction; Somatostatin; Thrombophilia; Young Adult | 2012 |
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?
Topics: Adult; Aged; Biomarkers; Cabergoline; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Female; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Pituitary ACTH Hypersecretion; Prospective Studies; Saliva; Treatment Outcome | 2014 |
11 other study(ies) available for ketoconazole and cabergoline
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease.
Topics: Adult; Cabergoline; Drug Therapy, Combination; Ergolines; Female; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Pituitary ACTH Hypersecretion; Prospective Studies; Treatment Outcome | 2010 |
Disappearance of pituitary macro adenoma with combination of ketoconazole and cabergoline treatment: an unusual case of Cushing's syndrome with interesting findings.
Topics: 14-alpha Demethylase Inhibitors; Adenoma; Adult; Antineoplastic Agents; Cabergoline; Cushing Syndrome; Diagnosis, Differential; Drug Therapy, Combination; Ergolines; Humans; Ketoconazole; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Severity of Illness Index; Tomography, X-Ray Computed | 2012 |
Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.
Topics: Adult; Aged; Cabergoline; Circadian Rhythm; Dopamine Agonists; Ergolines; Female; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Pituitary ACTH Hypersecretion; Quality of Life; Somatostatin; Surveys and Questionnaires; Young Adult | 2013 |
Glucocorticoid hypersensitivity syndrome--a case report.
Topics: 14-alpha Demethylase Inhibitors; Adult; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Glucocorticoids; Humans; Hypersensitivity; Ketoconazole | 2012 |
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectomy; Adult; Aged; Antineoplastic Agents; Cabergoline; Comorbidity; Enzyme Inhibitors; Ergolines; Female; Follow-Up Studies; Hirsutism; Hormone Antagonists; Hormones; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ketoconazole; Male; Metyrapone; Middle Aged; Mifepristone; Muscle Weakness; Muscular Atrophy; Neurosurgical Procedures; Obesity, Abdominal; Pituitary ACTH Hypersecretion; Pituitary Irradiation; Polycystic Ovary Syndrome; Retrospective Studies; Rosiglitazone; Somatostatin; Striae Distensae; Thiazolidinediones; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
An Overlooked Cause of Hypokalemia.
Topics: 14-alpha Demethylase Inhibitors; Adenoma; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Hypokalemia; Ketoconazole; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Neoplasms | 2017 |
Cabergoline in severe ectopic or occult Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adult; Aged; Cabergoline; Carcinoid Tumor; Cushing Syndrome; Dopamine Agonists; Female; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Intraductal Neoplasms; Rectal Neoplasms; Steroid Synthesis Inhibitors; Thymus Neoplasms; Treatment Outcome | 2019 |
β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Aged; Animals; Anti-Inflammatory Agents; beta-Arrestin 1; beta-Arrestin 2; Cabergoline; Cell Line, Tumor; Dexamethasone; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Ketoconazole; Male; Mice; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Neoplasms | 2020 |
Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort.
Topics: Cabergoline; Cushing Syndrome; Humans; Hydrocortisone; Hypokalemia; Ketoconazole; Pituitary ACTH Hypersecretion; Retrospective Studies | 2022 |